Fasenra 30 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FDQXG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,331
Award facts
- Contract value 100% obligated
- $7,330.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,330.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Fasenra 30 mg/ml syringes. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and was executed on July 22, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the broader federal pharmaceutical procurement marketplace.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499.999 billion and extending through November 2026. That overarching contract enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities nationwide. Fasenra, a biologic medication used in the treatment of severe eosinophilic asthma, represents one of the specialized pharmaceutical products available under this broader vehicle. DMS Pharmaceutical Group's established position as a primary pharmaceutical supplier to the Defense Logistics Agency demonstrates its critical role in maintaining the medical supply chain for military health systems.
Quick answers
Who was awarded contract SPE2DB25FDQXG?
SPE2DB25FDQXG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FDQXG worth?
The government has obligated $7,331 on SPE2DB25FDQXG.
Is contract SPE2DB25FDQXG an order under another contract?
Yes. SPE2DB25FDQXG is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQXG competed?
The extent of competition for SPE2DB25FDQXG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award